About Stata DX
Stata DX is a private company based in Boston, Massachusetts. It has reported $6,381,500 raised in three offerings on Form D since February 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Apr 7, 2026 | $1,891,500of $2.4M target | 7 | $270K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 12, 2024 | Mar 21, 2024 | $1,790,000of $5.0M target | 5 | $358K | EquityRule 506(b) | Form D ↗ |
| Jan 18, 2022 | Feb 7, 2022 | $2,700,000of $2.7M target | 5 | $540K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $6,381,500 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Stata DX's Form D filed Apr 7, 2026.
DL
Donald Ingber
Scientific Founder and director
Also a co-founder & advisor, director at Unravel Biosciences.
AS
Amarpreet Sawhney
Director
SJ
Sidhant Jena
Co-founder and director
Earlier filings also listed Michal Depa (executive officer, last listed Mar 2024).